These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15800234)

  • 1. Immunosuppressive drugs and the risk of cancer after organ transplantation.
    Dantal J; Soulillou JP
    N Engl J Med; 2005 Mar; 352(13):1371-3. PubMed ID: 15800234
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
    Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
    Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient.
    Pranteda G; Feliziani G; Grimaldi M; Paleologo G; Pranteda G; Melotti F; Camplone G
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1022-3. PubMed ID: 18194240
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
    Marco de F; Infante B; Giovanni S; Gesualdo L
    Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
    [No Abstract]   [Full Text] [Related]  

  • 6. Sirolimus for Kaposi's sarcoma.
    Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
    J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of sirolimus for kaposi sarcoma in a renal transplant recipient.
    Descoeudres B; Giannini O; Graf T; Steiger J; Mayr M
    Transplantation; 2006 May; 81(10):1472-4. PubMed ID: 16732189
    [No Abstract]   [Full Text] [Related]  

  • 9. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 10. Kaposi's sarcoma after renal transplantation.
    Kanitakis J
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16120869
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sirolimus offers advantages for kidney transplant patients].
    Med Klin (Munich); 2003 Feb; 98(2):VII. PubMed ID: 12638547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive drugs and the development of skin cancer after organ transplantation].
    Gjersvik P; Helsing P; Holdaas H; Bergan S
    Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2064-8. PubMed ID: 23038197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi Sarcoma in the Era of Rapamycin Remains a Therapeutic Challenge in Organ Transplant Recipients.
    Tunçer Vural A; Karataş Toğral A; Güleç AT; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):25-27. PubMed ID: 29527986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients.
    Barozzi P; Riva G; Vallerini D; Bosco R; Quadrelli C; Zanetti E; Potenza L; Forghieri F; Torelli G; Luppi M
    Transplantation; 2009 Aug; 88(4):597-8. PubMed ID: 19696647
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus does double duty after organ transplantation.
    McCaffrey P
    Lancet Oncol; 2005 May; 6(5):261. PubMed ID: 15889495
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.
    Guenova E; Metzler G; Hoetzenecker W; Berneburg M; Rocken M
    Arch Dermatol; 2008 May; 144(5):692-3. PubMed ID: 18490609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.